The LightPod Neo’s 650-microsecond pulse duration brings major benefits to the field of laser/light treatments of psoriasis. Its infrared 1064nm laser energy is clinically proven to be uniquely safe on skin tissue and is not associated with increased risks of skin aging and skin cancer linked to UV light as reported by the American Academy of Dermatology. Compared with pulsed dye lasers – a different laser modality that has been historically used to target vascularity – LightPod Neo energy travels much deeper into the skin tissue. As a result, it affects both superficial and deep plaque vasculature, yet treatment with LightPod Neo is gentler to the skin with a substantially reduced risk of bruising.
Vascular mass and vessel dilatation are greatly increased in psoriatic lesions. The LightPod Neo laser, which is an Nd:YAG 1064nm laser, is a modality that is deep penetrating and highly attracted to hemoglobin, thus it has the capability to deliver powerful energy to these vessels. It is also delivered in a unique 650-microsecond pulse duration which enables for a highly tolerable treatment, even with multiple passes of laser energy across the affected area. This treatment can effectively break down the hyperactive microvasculature and cut some of the blood supply to the psoriatic lesions.